Ariane Tom, PhD | 🧠🤖🦾

We're on the cover of @sciam! - Thanks for promoting our work in such a beautiful way @KarlDeisseroth #CLARITY #DeisserothLab #MatsciXNeuro

📣HUGE FUND NEWS! Honored to be selected to join the 1st inaugural @RecastCapital Accelerate program committed to supporting female & diverse fund managers Each of the VC funds selected received a no-strings-attached $100k paid for by @melindagates @pivotalventures 🐘🏕️💪

PsyMed Ventures GP @matisere participated as a panelist in the Brain Capital Innovation Summit. Fellow panelists include... - @Andrewmbarr at GreyMatter Capital - @ArianeCTom at Kaleida Capital - @Fayeks at Telosity Ventures We continue to invest in neurotech for mental health.

Thank you @ArianeCTom for giving a beautiful speech to kick off the event, and for serving as a Nucleate Mentor! We appreciate you and all the other experts in industry who came out to work with our teams!

Wondering what's happening with the neurotech investment outlook in this wacky economy? Look no further than this panel at Neurotech Reports with Jeremy Koff, Amy Kruse, @ArianeCTom, Suraj Mudichintala, and @langhalsn! Registration is still open.…lnkd.in/g_qhS7Re

This Friday we'll be hosting a star-studded Neurotechnology Development & Commercialization panel at the IEEE Brain, Mind and Body workshop (BMB 2022)! There's still time to register here: brain.ieee.org/event/ieee-bra…

Pleased to share that the final article from my thesis work at Stanford University has been published in Nature’s Scientific Reports! In this study, we used an innovative combination of materials characterization techniques, incl…lnkd.in/dxszwJaC lnkd.in/dyNUtsrn

A wonderful article and well-deserved highlight of Sergiu P. Pașca ‘s work at Stanford University. I am lucky to have collaborated with former postdocs Fikri Birey and Jimena Andersen to work with these functional 3D organoids during grad school, and am g…lnkd.in/gHHz6Qp2

This week, I'm attending the Alzheimer's Association® International Conference where the world’s leading scientists, clinical researchers, and clinicians will share breaking research discoveries for improved diagnosis and treatment for Alzheimer’s disease…lnkd.in/dhiXrD6v

Today is Nucleate San Diego's Final Pitch Showcase highlighting teams from its inaugural Activator program. I'm so proud to have served as a VC Mentor and Industry Advisor for this next generation of bioentrepreneurs! Thank you to…lnkd.in/gTSXATbK lnkd.in/gM2GTnRG

Blackrock Neurotech’s recent acquisition of MindX highlights the importance of both hardware and software innovation for implantable BCIs towards a more personalized and autonomous user experience for patients. #braincomputerinte…lnkd.in/gNawpMNA lnkd.in/g7PMrK_u

On the way to Houston for the Neuroengineering Initiative Conference! @RiceUniversity Neurocon.rice.edu #neuroengineering #neurotechnology #neuroscience #venturecapital #neuroinnovation

Happy #BrainAwarenessWeek!!!

Looking forward to the results! #neuroscience #brainimaging #alzheimersdisease #neurodegeneration #researchanddevelopment lnkd.in/gGhJXEiH

Exciting work out of UCSD! 🧠 🤖#precisionneuro #braininterface #neurotechnology #bioelectronics UC San Diego | Shadi Dayeh - would like to learn more about the cGMP facilities too! lnkd.in/gDZC9-9V

Aldo Carrascoso, CEO of InterVenn Biosciences, will be introducing the company at JPM 2022! Tune in on Wednesday, January 12th at 3 PM EST to meet the team and learn more about how glycoproteomic analysis will unlock novel insights…lnkd.in/gUujXbWR lnkd.in/gnJwMKyA

Another milestone achieved by @ExcisionBio, who announced FDA clearance of their IND for Phase 1/2 of EBT-101 CRISPR-based therapeutic for treatment of HIV. Read the press release: bit.ly/2Xkmx2r

Delayed post, but I am so proud of the team @InterVennBioSci!!! Congratulations on the announcement of this major funding round led by Softbank! It has been so exciting to see this company develop over time! fiercebiotech.com/medtech/interv…

We've made history today by validating the world's first glycoproteomic-powered LDT test. We are proud to announce InterVenn's "GLORI" test for Ovarian Cancer! #Glycoproteomics #HealthCare #GlycoPioneer #GlycoResearch #InterVennovation #BioTechnology businesswire.com/news/home/2021…

Incredible work @raflynn5 and @CarolynBertozzi !!! Looking forward to reading this in depth to continue building my understanding of #glycans

Excited to share our investment in Excision Bio, a company leveraging #CRISPR technologies to develop functional cures for HIV and other infectious diseases. Congrats @ExcisionBiotx! #genetherapy #startup #seriesA #venturecapital #therapeutics globenewswire.com/news-release/2…